<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on November 19, 2021</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT05123118</url>
  </required_header>
  <id_info>
    <org_study_id>STUDY00003067</org_study_id>
    <secondary_id>UL1TR001412</secondary_id>
    <nct_id>NCT05123118</nct_id>
  </id_info>
  <brief_title>Lung and Breast Cancer Prevention by an Integrated Intervention of Maternal Smoking Cessation and Breastfeeding</brief_title>
  <official_title>Lung and Breast Cancer Prevention by an Integrated Intervention of Maternal Smoking Cessation and Breastfeeding</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Xiaozhong Wen</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
    <collaborator>
      <agency>National Institutes of Health (NIH)</agency>
      <agency_class>NIH</agency_class>
    </collaborator>
  </sponsors>
  <source>State University of New York at Buffalo</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      This pilot clinical trial aims to integrate maternal smoking cessation and breastfeeding&#xD;
      interventions to enhance both cancer prevention behaviors. The investigators will recruit 40&#xD;
      daily smoking women in their early pregnancy and randomize them into the integrated&#xD;
      intervention or control group. Main outcomes include smoking abstinence and breastfeeding&#xD;
      rates at 6 months postpartum.&#xD;
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      The investigators are proposing the first randomized controlled trial to integrate maternal&#xD;
      smoking cessation and breastfeeding interventions to enhance both cancer prevention&#xD;
      behaviors. The investigators will recruit 40 daily smoking women in their 1st or 2nd&#xD;
      trimester of pregnancy (≤28 weeks) from local obstetric clinics, communities, and social&#xD;
      media. They will be randomized into either the intervention (N=20) or control group (N=20).&#xD;
      The two groups will complete the same number of sessions (6 during pregnancy and 3&#xD;
      postpartum), but focus on different topics. Specifically, the control group will receive&#xD;
      instructions on general pregnancy and infant care. The intervention group will receive&#xD;
      instructions on general pregnancy and infant care, plus an integrated multicomponent&#xD;
      intervention that promotes both smoking cessation and breastfeeding (i.e., education and&#xD;
      counseling, monitoring and feedback, and contingent financial incentives). Two female&#xD;
      Certified Lactation Counselors (interventionists) will be trained to run study sessions&#xD;
      during home visits. Interventionists will provide additional support via phone and text&#xD;
      messaging until 6 months postpartum. Main outcomes include smoking abstinence and&#xD;
      breastfeeding rates at 6 months postpartum within the duration of this award.&#xD;
    </textblock>
  </detailed_description>
  <overall_status>Recruiting</overall_status>
  <start_date type="Actual">January 1, 2021</start_date>
  <completion_date type="Anticipated">December 31, 2022</completion_date>
  <primary_completion_date type="Anticipated">July 31, 2022</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <intervention_model_description>The 40 eligible participants will be randomized into either the intervention (N=20) or control group (N=20). A sequence of random numbers in blocks of 2 will be used to ensure equal numbers of participants for each group over time.</intervention_model_description>
    <primary_purpose>Prevention</primary_purpose>
    <masking>Single (Outcomes Assessor)</masking>
    <masking_description>Research staff who collect and analyze outcome data will be blinded to participants' group assignments.</masking_description>
  </study_design_info>
  <primary_outcome>
    <measure>Smoking abstinence</measure>
    <time_frame>6 months postpartum</time_frame>
    <description>Based on their recorded daily numbers of cigarettes and cigars smoked after enrollment, the investigators will classify smoking abstinence status in the past 7 days (7-day point-prevalence).60,61 The self-reported smoking abstinence will be biochemically confirmed by urine cotinine tests (&lt;50 ng/mL).</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Breastfeeding intention</measure>
    <time_frame>35 weeks of pregnancy (the end of pregnancy)</time_frame>
    <description>During pregnancy, participants will report breastfeeding intention using questionnaires modified from the Infant Feeding Practices Study II.</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Breastfeeding status</measure>
    <time_frame>6 months postpartum</time_frame>
    <description>During postpartum, mothers will report breastfeeding status (exclusive, mixed with formula, non-breastfeeding) every month until 6 months postpartum.</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Breastfeeding frequency</measure>
    <time_frame>6 months postpartum</time_frame>
    <description>During postpartum, mothers will report breastfeeding frequency (times per day) every month until 6 months postpartum.</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Breastfeeding duration</measure>
    <time_frame>6 months postpartum</time_frame>
    <description>During postpartum, mothers will update breastfeeding duration (weeks) every month until 6 months postpartum.</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Formula duration</measure>
    <time_frame>6 months postpartum</time_frame>
    <description>During postpartum, mothers will update formula duration (weeks) every month until 6 months postpartum.</description>
  </primary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Anticipated">40</enrollment>
  <condition>Smoking, Cigarette</condition>
  <condition>Breastfeeding</condition>
  <arm_group>
    <arm_group_label>Integrated intervention</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>Integrated intervention of smoking cessation and breastfeeding</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Attention placebo control group</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>Instructions on general pregnancy and infant care</description>
  </arm_group>
  <intervention>
    <intervention_type>Behavioral</intervention_type>
    <intervention_name>Integrated intervention of smoking cessation and breastfeeding</intervention_name>
    <description>The intervention group will receive an integrated intervention of smoking cessation and breastfeeding: education and counseling, monitoring and feedback, and contingent financial incentives.</description>
    <arm_group_label>Integrated intervention</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Behavioral</intervention_type>
    <intervention_name>Attention placebo control</intervention_name>
    <description>Participants in the control group will receive usual prenatal care from physicians, nurses, or social workers. They will receive best standard care on smoking cessation and breastfeeding, including referral to the New York State Smokers' Quitline and the Special Supplemental Nutrition Program for Women, Infants, and Children (WIC).</description>
    <arm_group_label>Attention placebo control group</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:&#xD;
&#xD;
          -  Be 18 years or older&#xD;
&#xD;
          -  At ≤28 weeks of pregnancy&#xD;
&#xD;
          -  Daily smoking cigarettes and/or cigars in the past 7 days&#xD;
&#xD;
          -  Be able to read, listen, and talk in English&#xD;
&#xD;
        Exclusion Criteria:&#xD;
&#xD;
          -  Being diagnosed with cancer&#xD;
&#xD;
          -  Current heavy drinking (more than 2 drinks a day)&#xD;
&#xD;
          -  Current use of illicit substances&#xD;
&#xD;
          -  Medical conditions contraindicating breastfeeding such as HIV infection, active&#xD;
             tuberculosis, and breast removal&#xD;
      </textblock>
    </criteria>
    <gender>Female</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>Accepts Healthy Volunteers</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Xiaozhong Wen, MD, PhD</last_name>
    <role>Principal Investigator</role>
    <affiliation>State University of New York at Buffalo</affiliation>
  </overall_official>
  <overall_contact>
    <last_name>Xiaozhong Wen, MD, PhD</last_name>
    <phone>17168296811</phone>
    <email>xiaozhon@buffalo.edu</email>
  </overall_contact>
  <location>
    <facility>
      <name>Division of Behavioral Medicine Department of Pediatrics Jacobs School of Medicine and Biomedical Sciences State University of New York at Buffalo</name>
      <address>
        <city>Buffalo</city>
        <state>New York</state>
        <zip>14214</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Xiaozhong Wen</last_name>
      <phone>716-829-6811</phone>
      <email>xiaozhon@buffalo.edu</email>
    </contact>
    <contact_backup>
      <last_name>Xiaozhong Wen</last_name>
      <phone>7168296811</phone>
    </contact_backup>
    <investigator>
      <last_name>Xiaozhong Wen, MD, PhD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location_countries>
    <country>United States</country>
  </location_countries>
  <verification_date>November 2021</verification_date>
  <study_first_submitted>October 26, 2021</study_first_submitted>
  <study_first_submitted_qc>November 4, 2021</study_first_submitted_qc>
  <study_first_posted type="Actual">November 17, 2021</study_first_posted>
  <last_update_submitted>November 4, 2021</last_update_submitted>
  <last_update_submitted_qc>November 4, 2021</last_update_submitted_qc>
  <last_update_posted type="Actual">November 17, 2021</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor-Investigator</responsible_party_type>
    <investigator_affiliation>State University of New York at Buffalo</investigator_affiliation>
    <investigator_full_name>Xiaozhong Wen</investigator_full_name>
    <investigator_title>Associate Professor</investigator_title>
  </responsible_party>
  <keyword>Pregnancy</keyword>
  <keyword>Postpartum</keyword>
  <keyword>Smoking abstinence</keyword>
  <keyword>Breastfeeding intention</keyword>
  <keyword>Breastfeeding duration</keyword>
  <patient_data>
    <sharing_ipd>No</sharing_ipd>
  </patient_data>
  <provided_document_section>
    <provided_document>
      <document_type>Study Protocol and Statistical Analysis Plan</document_type>
      <document_has_protocol>Yes</document_has_protocol>
      <document_has_icf>No</document_has_icf>
      <document_has_sap>Yes</document_has_sap>
      <document_date>April 1, 2020</document_date>
      <document_url>https://ClinicalTrials.gov/ProvidedDocs/18/NCT05123118/Prot_SAP_000.pdf</document_url>
    </provided_document>
    <provided_document>
      <document_type>Informed Consent Form</document_type>
      <document_has_protocol>No</document_has_protocol>
      <document_has_icf>Yes</document_has_icf>
      <document_has_sap>No</document_has_sap>
      <document_date>September 17, 2020</document_date>
      <document_url>https://ClinicalTrials.gov/ProvidedDocs/18/NCT05123118/ICF_001.pdf</document_url>
    </provided_document>
  </provided_document_section>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

